Silicon Hills Wealth Management, LLC Regeneron Pharmaceuticals, Inc. Transaction History
Silicon Hills Wealth Management, LLC
- $176 Million
- Q2 2023
A detailed history of Silicon Hills Wealth Management, LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Silicon Hills Wealth Management, LLC holds 716 shares of REGN stock, worth $747,976. This represents 0.29% of its overall portfolio holdings.
Number of Shares
716
Previous 716
-0.0%
Holding current value
$747,976
Previous $588,000
12.59%
% of portfolio
0.29%
Previous 0.35%
Shares
7 transactions
Others Institutions Holding REGN
# of Institutions
1,426Shares Held
82.1MCall Options Held
835KPut Options Held
1.46M-
Vanguard Group Inc Valley Forge, PA8.93MShares$9.33 Billion0.17% of portfolio
-
Black Rock Inc. New York, NY8.57MShares$8.95 Billion0.19% of portfolio
-
Jpmorgan Chase & CO New York, NY7.73MShares$8.07 Billion0.68% of portfolio
-
State Street Corp Boston, MA4.84MShares$5.06 Billion0.21% of portfolio
-
Capital World Investors Los Angeles, CA4.65MShares$4.86 Billion0.76% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $112B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...